Patent details

Basic Information

Publication number:

EP1310243

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Revoked

Application number:

EP020283255

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Novel formulation comprising budesonide

French Title of Invention:

Nouvelle formulation contenant du budesonide

German Title of Invention:

Neue Arzneiformulierung enthaltend Budesonide

SPC Number:

Dates

Filing date:

28/11/1997

Grant date:

08/08/2007

EP Publication Date:

08/08/2007

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/05/2003

EP B1 Publication Date:

08/08/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

28/11/2017

Renunciation date:

Revocation date:

28/09/2009

Annulment date:

Owner

From:

28/11/1997

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN MICHEL

From:

25/09/2007

Address:

ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Nilsson Hans

Address:

Sweden (SE)

2

Name:

Santesson Gordon

Address:

Sweden (SE)

Priority

1

Priority Number:

9604486

Priority Date:

05/12/1996

Priority Country:

Sweden (SE)

2

Priority Number:

846960

Priority Date:

29/04/1997

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/00;

Filing date	Document type	Number of pages